Institute of Traditional Chinese Medicine and Natural Products, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, P. R. China.
Institute of Traditional Chinese Medicine and Natural Products, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, P. R. China.
Phytomedicine. 2016 Mar 15;23(3):283-92. doi: 10.1016/j.phymed.2015.12.021. Epub 2016 Jan 29.
Wedelia chinensis is a traditional medicinal herb used in Asia and it has been reported to possess various bioactivities including anti-inflammatory and anticancer effects. However, its anti-angiogenic activity has never been reported.
To determine the most potent anti-angiogenic component in W. chinensis and its molecular mechanism of action.
Initially, the active fraction of the plant was studied. Then, we determined the active components of the fraction and explored the mechanism of the most active compound.
The ethanol extract of W. chinensis and its four fractions with different polarities were evaluated for their anti-angiogenic activity in the Zebrafish model using quantitative endogenous alkaline phosphatase (EAP) assay. The molecular mechanism of the most active compound from the active fraction was studied using the real-time polymerase chain reaction (PCR) assay on Zebrafish embryos. The inhibitory effect of the most active compound on the proliferation, invasion and tube formation steps of angiogenesis was evaluated using the vascular endothelial growth factor (VEGF)-induced human umbilical vein endothelial cells (HUVECs) model, and the influences of the active compound on tyrosine phosphorylation of VEGF receptor (VEGFR-2) and its downstream signal pathway were evaluated by western blotting assay. Moreover, its anti-angiogenic effect was further evaluated by the VEGF-induced sprouts formation on aortic ring assay and the VEGF-induced vessel formation of mice on matrigel plug assay, respectively.
Petroleum ether (PE) fraction of the plant displayed potent anti-angiogenic activity. Twelve kaurane diterpenoids (1-12) isolated from this fraction showed quite different effects. Compounds 9-12 could dose-dependently inhibit vessel formation in the Zebrafish embryos while the others showed little inhibitory effect. Among the active diterpenoids, compound 10, 3α-cinnamoyloxy-9ß-hydroxy-ent-kaura-16-en-19-oic acid (CHKA), possessed the strongest effect, and it affected multiple molecular targets related to angiogenesis including VEGF and angiopoietin in Zerbrafish. Moreover, CHKA significantly inhibited a series of VEGF-induced angiogenesis processes including proliferation, invasion, and tube formation of endothelial cells. Besides, it directly inhibited VEGFR-2 tyrosine kinase activity and its downstream signaling pathways in HUVECs. CHKA also obviously inhibited sprouts formation of aortic ring, and block vessel formation in mice.
Our findings demonstrate that kaurane diterpenoids is one of anti-angiogenic components in W. chinensis, and CHKA may become a promising candidate for the development of anti-angiogenic agent.
薇甘菊是一种在亚洲被广泛应用于传统医学的草药,已被报道具有多种生物活性,包括抗炎和抗癌作用。然而,其抗血管生成活性尚未被报道。
确定薇甘菊中最强的抗血管生成成分及其作用机制。
首先研究植物的活性部位。然后,我们确定了该部位的活性成分,并探讨了最活跃化合物的作用机制。
采用定量内源性碱性磷酸酶(EAP) assay 法,在斑马鱼模型中评价薇甘菊乙醇提取物及其四种不同极性部位的抗血管生成活性。利用实时聚合酶链反应(PCR) assay 研究活性部位中最活跃化合物在斑马鱼胚胎中的作用机制。采用血管内皮生长因子(VEGF)诱导的人脐静脉内皮细胞(HUVECs)模型评价最活跃化合物对血管生成的增殖、侵袭和管形成步骤的抑制作用,并通过 Western blot assay 评价该化合物对 VEGF 受体(VEGFR-2)酪氨酸磷酸化及其下游信号通路的影响。此外,通过 VEGF 诱导的主动脉环上芽形成实验和 VEGF 诱导的小鼠基质胶塞血管生成实验,分别进一步评价该化合物的抗血管生成作用。
植物的石油醚(PE)部位显示出很强的抗血管生成活性。从该部位分离得到的 12 个贝壳杉烷二萜(1-12)表现出截然不同的作用。化合物 9-12 可剂量依赖性地抑制斑马鱼胚胎中的血管形成,而其他化合物则几乎没有抑制作用。在活性二萜中,化合物 10,3α-肉桂酰氧基-9β-羟基-ent-贝壳杉-16-烯-19-酸(CHKA)的作用最强,它影响了与血管生成相关的多个分子靶点,包括斑马鱼中的 VEGF 和血管生成素。此外,CHKA 显著抑制了一系列 VEGF 诱导的血管生成过程,包括内皮细胞的增殖、侵袭和管形成。此外,它直接抑制了 HUVECs 中的 VEGFR-2 酪氨酸激酶活性及其下游信号通路。CHKA 还明显抑制了主动脉环上的芽形成,并阻止了小鼠中的血管形成。
我们的研究结果表明,贝壳杉烷二萜是薇甘菊中的一种抗血管生成成分,CHKA 可能成为开发抗血管生成剂的有前途的候选药物。